Narrative review reveals advances in ESR1 testing for advanced breast cancer, highlighting liquid biopsy diagnostics to overcome endocrine resistance.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: